Neuronetics Net Income From Continuing Ops Over Time
| STIM Stock | USD 1.46 -0.14 -8.75% |
This page compares Neuronetics' fundamentals over time, not in one-period snapshots. All values are presented as reference data.
Use Neuronetics Performance alongside Neuronetics Correlation to build context for Neuronetics.Neuronetics | Build portfolio with Neuronetics Stock |
Earnings Share -0.54 | Revenue Per Share | Quarterly Revenue Growth 0.857 | Return On Assets | Return On Equity |
Neuronetics' market capitalization and book value each provide useful but distinct information about the business. Together, market value, book value, and intrinsic value form a multi-dimensional view.
Neuronetics' estimated value and market price are complementary but separate measures of worth. All metrics are derived from available inputs and shown for reference.
Peer Comparison: Net Income From Continuing Ops
Compare Neuronetics and related stocks such as Prenetics Global, Nyxoah, and Atlantic International Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRE | -20.2 M | -20.2 M | -20.2 M | -20.2 M | -20.2 M | -20.2 M | -20.2 M | -20.2 M | -20.2 M | -20.2 M | -2 M | -174 M | -190.5 M | -19.1 M | -49.8 M | -44.8 M | -47.1 M |
| NYXH | -10.4 M | -10.4 M | -10.4 M | -10.4 M | -10.4 M | -10.4 M | -10.4 M | -10.4 M | -9.1 M | -7.3 M | -12.2 M | -27.6 M | -31.2 M | -45.6 M | -59.2 M | -53.3 M | -50.6 M |
| ATLN | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -3.7 M | -4.1 M | -5.6 M | -135.5 M | -121.9 M | -115.8 M |
| OABI | -13.6 M | -13.6 M | -13.6 M | -13.6 M | -13.6 M | -13.6 M | -13.6 M | -13.6 M | -13.6 M | -13.6 M | -17.6 M | -27 M | -22.3 M | -29.7 M | -62 M | -64.8 M | -61.5 M |
| CATX | -5.1 M | -5.1 M | -5.1 M | -5.1 M | -5.1 M | -5.1 M | -5.1 M | -5.1 M | -5.1 M | -3.4 M | -3.4 M | -7.3 M | -37.5 M | -37.5 M | -78.3 M | -103.6 M | -98.5 M |
| OSUR | -8.8 M | -8.8 M | -15.1 M | -11.2 M | -4.6 M | 8.2 M | 19.7 M | 30.9 M | 20.4 M | 16.7 M | -14.9 M | -23 M | -17.9 M | 48.6 M | -19.5 M | -68.7 M | -65.3 M |
| PROF | -8.5 M | -8.5 M | -8.5 M | -8.5 M | -8.5 M | -8.5 M | -16.3 M | -18.8 M | -20.8 M | -20.2 M | -21.6 M | -30.7 M | -28.7 M | -28.6 M | -27.8 M | -42.6 M | -40.4 M |
| CDXS | -16.6 M | -16.6 M | -30.9 M | -41.3 M | -19.1 M | -7.6 M | -8.6 M | -23 M | -10.9 M | -11.9 M | -24 M | -21.3 M | -33.6 M | -81.7 M | -65.3 M | -44 M | -46.2 M |
| SGMO | -35.8 M | -35.8 M | -22.3 M | -26.6 M | -26.4 M | -40.7 M | -71.7 M | -54.6 M | -68.9 M | -95.4 M | -121.1 M | -178.3 M | -192.3 M | -249.5 M | -97.9 M | -88.1 M | -92.6 M |
My Equities
My Current Equities and Potential Positions
| Neuronetics | STIM |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 3222 Phoenixville Pike, |
| Exchange | NASDAQ Exchange |
USD 1.46